Community-based management plan for sarcopenia in older adults
-
摘要: 肌少症是一种以骨骼肌量和肌力进行性下降为特征的老年综合征,显著增加老年人跌倒、失能风险,严重影响老年人的生活质量。我国基层医疗服务机构对于肌少症的认识与研究起步较晚,作为肌少症防控的主战场,亟需规范化的管理方案。本方案由北京市月坛社区卫生服务中心牵头,基于国内外最新共识与指南,经全科医学、老年医学、营养学、康复医学等多学科专家团队反复讨论制定,旨在为基层医疗工作者提供系统指导。该方案内容包括:明确以65岁以上社区老年人为重点管理对象,遵循“预防为主、防治结合”及“个性化干预”原则;构建以全科医生为核心,联合护士、康复师、营养师的多学科协作团队;强调通过线上线下结合开展科普教育;利用小腿围、SARC-CalF量表、握力测试进行早期筛查;采用肌量、肌力及躯体功能综合评估和诊断;以营养及运动干预为核心,推荐每日蛋白质摄入≥1.2 g/(kg·d)并适当补充维生素D,同时结合抗阻与有氧训练,制定个体化运动处方;并建立转诊标准与随访机制,旨在规范社区肌少症管理流程,改善患者肌肉功能,实现科学防治。Abstract: Sarcopenia is a geriatric syndrome characterized by progressive loss of skeletal muscle mass and strength, which significantly increases the risk of falls and disability among older adults and severely impairs quality of life. In China, primary healthcare institutions have relatively limited experience in the recognition and management of sarcopenia, and standardized management strategies remain lacking. As the frontline of sarcopenia prevention and control, primary care settings require practical and evidence-based management protocols. This program was led by the Yuetan Community Health Service Center in Beijing and developed based on the latest domestic and international consensus and guidelines. It was formulated through repeated discussions by a multidisciplinary expert team including general practitioners, geriatricians, nutritionists, and rehabilitation specialists. It aims to provide systematic guidance for primary healthcare workers. The program identified adults aged 65 years and older as the primary management population and follows the principles of "prevention first, combining prevention and treatment" and "personalized intervention". A multidisciplinary collaborative model is established, with general practitioners at the core coordinators and support from nurses, rehabilitation specialists, and nutritionists. Emphasized health education and public awareness through both online and offline chan-nels. Early screening is conducted using calf circumference, SARC-CalF questionnaire, and handgrip strength testing, followed by comprehensive assessment and diagnosis based on muscle mass, muscle strength, and physical performance. Interventions focus on nutrition and exercise, recommending a daily protein intake of ≥1.2 g/kg body weight with appropriate vitamin D supplementation, combined with resistance and aerobic exercise to develop individualized exercise prescriptions. Referral criteria and follow-up mechanisms are also clearly defined. The goal is to standardize community-based sarcopenia management procedures, improve muscle function in older adults, and achieve evidence-based prevention and treatment of sarcopenia.
-
表 1 肌少症自我筛查量表(SARC-CalF)
Table 1. SARC-CalF
条目 评分 Q1小腿围测量值:cm(填写两侧小腿围平均值) 10=男性≤34 cm,女性≤33 cm;0=男性>34 cm,女性>33 cm Q2提起并搬运4.5公斤重物是否困难? 0=无困难,1=有一些困难,2=有很大困难或不能完成 Q3步行走过房间是否困难? 0=无困难,1=有一些困难,2=有很大困难,需要辅助,或不能完成 Q4从床上或椅子上起身是否困难? 0=无困难,1=有一些困难,2=有很大困难,或没有他人帮助不能完成 Q5上10级台阶是否困难? 0=无困难,1=有一些困难,2=有很大困难或不能完成 Q6过去1年内您跌倒了多少次? 0=没有,1=1~3次,2=4次以上 注:SARC-CalF量表评分≥11分为筛查阳性。 表 2 肌少症运动处方
Table 2. Exercise prescription for sarcopenia
阶段 项目 内容 第一阶段:热身 进行5 min的拉伸运动有助于预防肌肉拉伤 第二阶段:正式运动 抗阻训练(30 min) 卧位。a1.双桥运动:20次/组,3组/d;b1.侧桥运动(左右两侧):20次/组,3组/d;c1.空中蹬自行车训练:10次/组,3组/d;d1.直腿抬高训练(包括髋屈曲、外展、后伸动作):20次/组,2组/d 坐位。a2.上肢哑铃举重训练,包括腕关节屈曲、上臂及肩部的屈曲、外展和后伸动作:10次/组,3组/d;b2.下肢弹力带抗阻训练,专注于膝关节的伸展动作:20次/组,3组/d;c2.使用股四头肌训练仪进行抗阻训练,20次/组,3组/d 立位。a3.下肢弹力带抗阻训练,包括髋屈曲、外展、后伸动作:10次/组,3组/d;b3.功率自行车抗阻训练:每组持续10 min 有氧运动 a4.散步:持续30 min;b4.快走:持续20 min;c4.慢跑:持续10 min 第三阶段:恢复整理 5 min的温和拉伸有助于预防乳酸的积累 注:正式的运动时段可以根据实际情况灵活安排,但累积的运动时间应≥30 min,并且建议每周进行3~4次。应确保每日对运动组合进行记录。 表 3 肌少症患者随访记录表
Table 3. Muscle atrophy patient follow-up record form
肌少症患者随访记录表 一、基本信息 姓名:________性别:____年龄:____ 档案号:________随访日期:________ 随访方式:□门诊□家访□电话/视频 二、随访内容 1. 症状与功能评估 □近3个月跌倒史:____次(时间/情景:________________) □ 5次起立实验时间:____秒 □ 6 m步速:____秒 □握力:____kg □日常活动能力(ADL量表评分):____分 2. 营养状况 每日蛋白质摄入:□达标(≥1.2 g/kg体重) □不足 维生素D补充:□是(剂量____ IU/日) □否 每日热量摄入:________□达标□未达标 其他营养问题:________________________ 3. 运动依从性 抗阻训练:□每周≥3次□偶尔□未执行 有氧运动:□每周≥150分钟□偶尔□未执行 运动障碍原因:□时间不足□疼痛□缺乏指导□其他____ 4. 合并症与用药 新增疾病:________________________ 药物调整(如激素、降糖药等):________________ 5. 辅助检查 □肌肉量检测(BIA/DXA):____kg(较前□增加□稳定□下降) □ 25(OH)D水平:____nmol/L □其他:________________ 三、干预调整方案 1. 运动处方:新增/调整:□抗阻训练(____组/次) □平衡训练□其他____ 2. 营养建议:□增加蛋白质至____g/日□补充维生素D ____IU/日□增加热量至____ 3. 药物调整:________________________ 4. 转诊建议:□康复科□营养科□老年科□其他________ 四、下次随访计划 时间:____年____月____日 重点目标:□肌力提升□跌倒预防□营养改善□其他____ 五、备注 患者疑问:________________________ 家属沟通要点:______________________ 随访医生签名:________ 随访时间:________ 使用说明: 1.随访频率:建议初期每3个月1次,稳定后6个月1次。 2.红色预警:出现≥2次跌倒或ADL显著下降需紧急干预。 3.多学科协作:合并骨质疏松、糖尿病等需联合专科管理。 -
[1] 刘娟, 丁清清, 周白瑜, 等. 中国老年人肌少症诊疗专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(8): 943-952.LIU J, DING Q Q, ZHOU B Y, et al. Chinese expert consensus on diagnosis and treatment for elderly with sarcopenia(2021)[J]. Chin J Geriatr, 2021, 40(8): 943-952. [2] 崔华, 王朝晖, 吴剑卿, 等. 老年人肌少症防控干预中国专家共识(2023)[J]. 中华老年医学杂志, 2023, 42(2): 144-153.CUI H, WANG Z H, WU J Q, et al. Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023)[J]. Chin J Geriatr, 2023, 42(2): 144-153. [3] 周璇, 陈文英, 张珊, 等. 社区老年人不同程度肌少症与跌倒风险的关系研究[J]. 中华全科医学, 2021, 19(5): 821-824, 845. doi: 10.16766/j.cnki.issn.1674-4152.001926ZHOU X, CHEN W Y, ZHANG S, et al. Study on the relationship between different degrees of sarcopenia and the risk of falls in the elderly in the community[J]. Chinese Journal of General Practice, 2021, 19(5): 821-824, 845. doi: 10.16766/j.cnki.issn.1674-4152.001926 [4] 于宝海, 吴文娟. 2018欧洲肌少症共识解读[J]. 河北医科大学学报, 2019, 40(4): 373-379, 384.YU B H, WU W J. Understanding the 2018 european consensus on sarcopenia[J]. Journal of Heibei Medical university, 2019, 40(4): 373-379, 384. [5] 黄宏兴, 史晓林, 李盛华, 等. 肌少-骨质疏松症专家共识[J]. 中国骨质疏松杂志, 2022, 28(11): 1561-1570.HUANG H X, SHI X L, LI S H, et al. Sarcopenia-osteoporosis expert consensus[J]. Chin J Osteoporosis, 2022, 28(11): 1561-1570. [6] 于普林, 高超, 周白瑜, 等. 预防老年人肌少症核心信息中国专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(8): 953-954.YU P L, GAO C, ZHOU B Y, et al. Chinese expert consensus on core information for sarcopenia prevention in the elderly (2021)[J]. Chin J Geriatr, 2021, 40(8): 953-954. [7] CHEN L K, ARAI H, ASSANTACHAI P, et al. Roles of nutrition in muscle health of community-dwelling older adults: evidence-based expert consensus from Asian Working Group for Sarcopenia[J]. J Cachexia Sarcopenia Muscle, 2022, 13(3): 1653-1672. doi: 10.1002/jcsm.12981 [8] 王颖, 颜轶隽, 刘蕾, 等. 抗阻力运动联合营养干预对老年2型糖尿病合并肌少症患者血糖稳定性影响的临床研究[J]. 中国全科医学, 2025, 28(21): 2604-2610.WANG Y, YAN Y J, LIU L, et al. Effects of resistance exercise combined with nutritional intervention on blood glucose stability in elderly patients with type 2 diabetes mellitus[J]. Chinese General Practice, 2025, 28(21): 2604-2610. [9] ABE T, LOENNEKEJ P, THIEBAUD R S, et al. The bigger the hand, the bigger the diference? Implications for testing strength with 2 popular handgrip dynamometers[J]. J Sport Rehabil, 2019, 28(3): 278-282. doi: 10.1123/jsr.2017-0189 [10] 张勤, 康琳, 王建业, 等. 老年人肌少症门诊管理规范中国专家共识(2024版)[J]. 中华老年医学杂志, 2024, 43(12): 1511-1517.ZHANG Q, KANG L, WANG J Y, et al. Chinese expert consensus on standardized outpatient management of sarcopenia in the elderly (2024 edition)[J]. Chin J Geriatr, 2024, 43(12): 1511-1517. [11] LI Z, CUI M, YU K, et al. Effects of nutrition supplementation and physical exercise on muscle mass, muscle strength and fat mass among sarcopenic elderly: a randomized controlled trial[J]. Appl Physiol Nutr Metab, 2021, 6(5): 494-500. [12] 梁碧娟, 李华, 王志敏, 等. 营养干预联合抗阻运动对老年肌少症的影响[J]. 昆明医科大学学报, 2023, 44(6): 92-96.LIANG B J, LI H, WANG Z M, et al. Effect of nutritional intervention combined with resistance exercise on senile sarcopenia[J]. J KMU, 2023, 44(6): 92-96. [13] 安广华. 有氧联合抗阻运动对老年肌少症患者的康复效果观察[J]. 中国现代药物应用, 2024, 18(19): 174-176.AN G H. Observation of the rehabilitation effect of aerobic combined with resistance exercise on elderly patients with sarcopenia[J]. Chin J Med Drug Appl, 2024, 18(19): 174-176. [14] 孙建琴, 袁武科, 黄佳妮. 《营养在社区老年人肌肉健康中的作用: 亚洲肌肉减少症工作组循证专家共识》解读[J]. 肿瘤代谢与营养电子杂志, 2022, 9(5): 536-537.SUN J Q, YUAN W K, HUANG J N. Interpretation of roles of nutrition in muscle health of community-dwelling older adults: evidence-based expert consensus from the asian working group for sarcopenia[J]. Electronic Jourmal of Metabolism and Nutrition of Cancer, 2022, 9(5): 536-537. [15] 张片红, 郭惠兰. 老年患者营养诊疗专家共识[J]. 浙江医学, 2023, 45(2): 113-120.ZHANG P H, GUO H L. Expert consensus on nutritional diagnosis and treatment for elderly patients[J]. Zhejiang Medical Journal, 2023, 45(2): 113-120. [16] LIN C C, SHIH M H, CHEN C D, et al. Effects of adequate dietary protein with wheyprotein, leucine, and vitamin D supplementation on sarcopenia in older adults: an open-la-bel parallel-group study[J]. Clin Nutr, 2021, 40(3): 1323-1329. doi: 10.1016/j.clnu.2020.08.017 [17] 康军仁, 王梅, 朱婧, 等. 肌少症及合并慢性疾病患者的医学营养管理及运动干预专家共识(2024版)[J]. 中华临床营养杂志, 2025, 33(1): 1-15.KANG J R, WANG M, ZHU J, et al. Expert consensus on medical nutrition management and exercise intervention for patients with sarcopenia and concomitant chronic diseases (2024)[J]. Chin J Clin Nutr, 2025, 33(1): 1-15. [18] 肌少症膳食营养处方及运动干预中国专家共识工作组, 孙建琴, 陈洁, 等. 肌少症膳食营养处方及运动干预中国专家共识(2025)[J]. 营养学报, 2025, 47(1): 1-11.Chinese Expert Consensus Working Group on Dietary Nutrition Prescriptions and Exercise Intervention for Sarcopenia, SUN J Q, CHEN J, et al. Chinese expert consensus on dietary nutrition prescription and exercise intervention for sarcopenia (2025)[J]. Acta Nutrimenta Sinica, 2025, 47(1): 1-11. [19] 中华医学会老年医学分会, 《中华老年医学杂志》编辑委员会. 老年人肌少症口服营养补充中国专家共识(2019)[J]. 中华老年医学杂志, 2019, 38(11): 1193-1197.Geriatrics Branch Chinese Medical Association, Editorial Board of the Chinese Journal of Geriatrics. Chinese expert consensus on oral nutrition supplementation for sarcopenia of the elderly (2019)[J]. Chin J Geriatr, 2019, 38(11): 1193-1197. [20] CAMACHO P M, PETAK S M, BINKLEY N, et al. American Association of Clinical Endocrinologists / American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis 2020 update[J]. Endocr Pract, 2020, 26 (sup1): 1-46. [21] 中华医学会骨质疏松和骨矿盐疾病分会. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 1-19.Chinese Society of Osteoporosis And Bone Mineral Research. Clinical application consensus on vitamin D and its analogues[J]. Chin J Osteoporosis and Bone Miner Res, 2018, 11(1): 1-19. -
下载: